259 related articles for article (PubMed ID: 28497397)
1. Xuebijing Injection () and Resolvin D1 Synergize Regulate Leukocyte Adhesion and Improve Survival Rate in Mice with Sepsis-Induced Lung Injury.
Zhang SK; Zhuo YZ; Li CX; Yang L; Gao HW; Wang XM
Chin J Integr Med; 2018 Apr; 24(4):272-277. PubMed ID: 28497397
[TBL] [Abstract][Full Text] [Related]
2. Resolvin D1 Promotes SIRT1 Expression to Counteract the Activation of STAT3 and NF-κB in Mice with Septic-Associated Lung Injury.
Zhuo Y; Zhang S; Li C; Yang L; Gao H; Wang X
Inflammation; 2018 Oct; 41(5):1762-1771. PubMed ID: 30014231
[TBL] [Abstract][Full Text] [Related]
3. Xuebijing exerts protective effects on lung permeability leakage and lung injury by upregulating Toll-interacting protein expression in rats with sepsis.
Liu MW; Wang YH; Qian CY; Li H
Int J Mol Med; 2014 Dec; 34(6):1492-504. PubMed ID: 25269519
[TBL] [Abstract][Full Text] [Related]
4. [To explore the preventive and therapeutic effects of Xuebijing injection on acute lung injury induced by cardiopulmonary bypass in rats by regulating the expression of microRNA-17-5p and its mechanism].
Xu Z; Liu D; Li K; Li X; Song L
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul; 31(7):867-872. PubMed ID: 31441412
[TBL] [Abstract][Full Text] [Related]
5. Anti-sepsis protection of Xuebijing injection is mediated by differential regulation of pro- and anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis.
Chen X; Feng Y; Shen X; Pan G; Fan G; Gao X; Han J; Zhu Y
J Ethnopharmacol; 2018 Jan; 211():358-365. PubMed ID: 28987599
[TBL] [Abstract][Full Text] [Related]
6. Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response.
Chen F; Fan XH; Wu YP; Zhu JL; Wang F; Bo LL; Li JB; Bao R; Deng XM
Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):457-64. PubMed ID: 24072678
[TBL] [Abstract][Full Text] [Related]
7. Resolvin D1 protects mice from LPS-induced acute lung injury.
Wang B; Gong X; Wan JY; Zhang L; Zhang Z; Li HZ; Min S
Pulm Pharmacol Ther; 2011 Aug; 24(4):434-41. PubMed ID: 21501693
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Xuebijing Injection Exhibiting Protective Efficacy on Sepsis by Inhibiting the Expression of HMGB1 in Septic Rat Model Designed by Cecal Ligation and Puncture.
Chen S; Dai G; Hu J; Rong A; Lv J; Su L; Wu X
Am J Ther; 2016; 23(6):e1819-e1825. PubMed ID: 26313171
[TBL] [Abstract][Full Text] [Related]
9. Dietary glutamine supplementation reduces cellular adhesion molecule expression and tissue myeloperoxidase activity in mice with gut-derived sepsis.
Yeh CL; Hsu CS; Yeh SL; Lin MT; Chen WJ
Nutrition; 2006 Apr; 22(4):408-13. PubMed ID: 16458482
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics approach in lung tissue of septic rats and the interventional effects of Xuebijing injection using UHPLC-Q-Orbitrap-HRMS.
Xu T; Zhou L; Shi Y; Liu L; Zuo L; Jia Q; Du S; Kang J; Zhang X; Sun Z
J Biochem; 2018 Dec; 164(6):427-435. PubMed ID: 30165618
[TBL] [Abstract][Full Text] [Related]
11. Xuebijing Injection () increases early survival rate by alleviating pulmonary vasopermeability in rats subjected to severe burns.
Dai YL; Li JY; Bai HY; Liu S; Dou YQ; Hu S
Chin J Integr Med; 2017 Sep; 23(9):703-708. PubMed ID: 28497392
[TBL] [Abstract][Full Text] [Related]
12. Identification of NF-κB Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF.
Jiang M; Zhou M; Han Y; Xing L; Zhao H; Dong L; Bai G; Luo G
J Ethnopharmacol; 2013 May; 147(2):426-33. PubMed ID: 23524166
[TBL] [Abstract][Full Text] [Related]
13. GC/MS-based metabonomics approach reveals effects of Xuebijing injection in CLP induced septic rats.
Jiang Y; Zou L; Liu S; Liu X; Chen F; Liu X; Zhu Y
Biomed Pharmacother; 2019 Sep; 117():109163. PubMed ID: 31238257
[TBL] [Abstract][Full Text] [Related]
14. Xuebijing Ameliorates Sepsis-Induced Lung Injury by Downregulating HMGB1 and RAGE Expressions in Mice.
Wang Q; Wu X; Tong X; Zhang Z; Xu B; Zhou W
Evid Based Complement Alternat Med; 2015; 2015():860259. PubMed ID: 25821501
[TBL] [Abstract][Full Text] [Related]
15. Polyunsaturated fatty acid-derived lipid mediator Resolvin D1 alleviates sepsis-induced disseminated intravascular coagulation via Caspase-1/Gasdermin D pyroptotic pathway.
Zhang W; Bhandari S; Ding Y; Luo J; Feng B; Jiang Y; Chen T; Wei J; Pan X; Weng H; Ding Z; Chen J; Chen X; Gong Y; Li H; Jin S; Hao Y
Clin Nutr; 2024 Jun; 43(6):1372-1383. PubMed ID: 38678822
[TBL] [Abstract][Full Text] [Related]
16. Disturbed homeostasis of lung intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 during sepsis.
Laudes IJ; Guo RF; Riedemann NC; Speyer C; Craig R; Sarma JV; Ward PA
Am J Pathol; 2004 Apr; 164(4):1435-45. PubMed ID: 15039231
[TBL] [Abstract][Full Text] [Related]
17. Xuebijing injection in septic rats mitigates kidney injury, reduces cortical microcirculatory disorders, and suppresses activation of local inflammation.
Liu J; Wang Z; Lin J; Li T; Guo X; Pang R; Dong L; Duan M
J Ethnopharmacol; 2021 Aug; 276():114199. PubMed ID: 33989736
[TBL] [Abstract][Full Text] [Related]
18. [Role and related mechanism of resolvin D1 in lung ischemia reperfusion injury in rats].
Xia J; Xue JY; Du J; Wu GW; Hu XT; Zhao QF
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(14):1111-1115. PubMed ID: 30982262
[No Abstract] [Full Text] [Related]
19. [Effect of combination therapy with propofol and hydrogen-rich saline on organ damage and cytokines in a murine model of sepsis].
Hong Y; Chen H; Yu Y; Xie K
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Apr; 29(4):316-320. PubMed ID: 28420464
[TBL] [Abstract][Full Text] [Related]
20. Xuebijing injection treatment inhibits vasopermeability and reduces fluid requirements in a canine burn model.
Tang FB; Dai YL; Hu S; Ma LQ; Li JY; Zhang HP; Zhang WH; Li YG; Wang HB; Lin HY; Hu Q; Li L
Eur J Trauma Emerg Surg; 2017 Dec; 43(6):875-882. PubMed ID: 28070608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
